CN115429866B - 一种治疗胆囊炎的中药组合物及其制备方法 - Google Patents
一种治疗胆囊炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN115429866B CN115429866B CN202110621563.2A CN202110621563A CN115429866B CN 115429866 B CN115429866 B CN 115429866B CN 202110621563 A CN202110621563 A CN 202110621563A CN 115429866 B CN115429866 B CN 115429866B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- extracting
- traditional chinese
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 339
- 239000000203 mixture Substances 0.000 title claims abstract description 185
- 201000001352 cholecystitis Diseases 0.000 title claims abstract description 134
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 230000001737 promoting effect Effects 0.000 claims abstract description 52
- 210000000941 bile Anatomy 0.000 claims description 103
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 79
- 239000000843 powder Substances 0.000 claims description 78
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 72
- 238000005303 weighing Methods 0.000 claims description 54
- 238000002156 mixing Methods 0.000 claims description 52
- 239000003826 tablet Substances 0.000 claims description 52
- 239000000284 extract Substances 0.000 claims description 50
- 206010008617 Cholecystitis chronic Diseases 0.000 claims description 44
- 230000001965 increasing effect Effects 0.000 claims description 42
- 239000000243 solution Substances 0.000 claims description 38
- 239000000341 volatile oil Substances 0.000 claims description 37
- 230000002829 reductive effect Effects 0.000 claims description 31
- 238000001035 drying Methods 0.000 claims description 25
- 238000001914 filtration Methods 0.000 claims description 24
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 21
- 235000008397 ginger Nutrition 0.000 claims description 21
- 240000004980 Rheum officinale Species 0.000 claims description 20
- 235000008081 Rheum officinale Nutrition 0.000 claims description 20
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 20
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 19
- 240000001341 Reynoutria japonica Species 0.000 claims description 19
- 239000002775 capsule Substances 0.000 claims description 16
- 241001571764 Lysimachia christinae Species 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 12
- 238000010298 pulverizing process Methods 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 230000000202 analgesic effect Effects 0.000 claims description 11
- 244000183685 Citrus aurantium Species 0.000 claims description 10
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 10
- 241001522129 Pinellia Species 0.000 claims description 10
- 241000219061 Rheum Species 0.000 claims description 10
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 10
- 230000028327 secretion Effects 0.000 claims description 10
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 9
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 9
- 240000001851 Artemisia dracunculus Species 0.000 claims description 9
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 9
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 9
- 244000111489 Gardenia augusta Species 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000001138 artemisia absinthium Substances 0.000 claims description 9
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 9
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 8
- 244000153955 Reynoutria sachalinensis Species 0.000 claims description 8
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims description 8
- 241000632227 Antenoron Species 0.000 claims description 6
- 244000236521 Bupleurum rotundifolium Species 0.000 claims description 6
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 claims description 6
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 235000012239 silicon dioxide Nutrition 0.000 claims description 3
- 229940124599 anti-inflammatory drug Drugs 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims 4
- 241000050051 Chelone glabra Species 0.000 claims 1
- 244000170916 Paeonia officinalis Species 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 210000000232 gallbladder Anatomy 0.000 abstract description 136
- 230000000694 effects Effects 0.000 abstract description 77
- 210000004185 liver Anatomy 0.000 abstract description 63
- 208000002193 Pain Diseases 0.000 abstract description 39
- 230000036407 pain Effects 0.000 abstract description 39
- 210000002784 stomach Anatomy 0.000 abstract description 31
- 208000004880 Polyuria Diseases 0.000 abstract description 24
- 230000035619 diuresis Effects 0.000 abstract description 23
- 208000024891 symptom Diseases 0.000 abstract description 19
- 239000000463 material Substances 0.000 abstract description 13
- 230000008506 pathogenesis Effects 0.000 abstract description 9
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 7
- 235000008216 herbs Nutrition 0.000 abstract description 5
- 241000721047 Danaus plexippus Species 0.000 abstract description 4
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 167
- 229940079593 drug Drugs 0.000 description 128
- 238000012360 testing method Methods 0.000 description 86
- 238000002474 experimental method Methods 0.000 description 70
- 241000699670 Mus sp. Species 0.000 description 54
- 230000003110 anti-inflammatory effect Effects 0.000 description 54
- 238000000034 method Methods 0.000 description 52
- 230000002279 cholagogic effect Effects 0.000 description 47
- 241000700159 Rattus Species 0.000 description 46
- 230000008961 swelling Effects 0.000 description 37
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 30
- 230000037396 body weight Effects 0.000 description 30
- 230000005764 inhibitory process Effects 0.000 description 29
- 201000010099 disease Diseases 0.000 description 26
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 26
- 239000000126 substance Substances 0.000 description 26
- 210000002966 serum Anatomy 0.000 description 25
- 208000000197 Acute Cholecystitis Diseases 0.000 description 23
- 206010008614 Cholecystitis acute Diseases 0.000 description 23
- 230000002354 daily effect Effects 0.000 description 23
- 230000035622 drinking Effects 0.000 description 23
- 239000002904 solvent Substances 0.000 description 22
- 230000036541 health Effects 0.000 description 21
- 238000011160 research Methods 0.000 description 21
- 241000700198 Cavia Species 0.000 description 20
- 241000699666 Mus <mouse, genus> Species 0.000 description 20
- 241000700199 Cavia porcellus Species 0.000 description 19
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 19
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 19
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 19
- 230000006870 function Effects 0.000 description 18
- 102000053187 Glucuronidase Human genes 0.000 description 17
- 108010060309 Glucuronidase Proteins 0.000 description 17
- 241000234314 Zingiber Species 0.000 description 17
- 238000010171 animal model Methods 0.000 description 17
- 238000009826 distribution Methods 0.000 description 17
- 210000004400 mucous membrane Anatomy 0.000 description 17
- 239000011734 sodium Substances 0.000 description 17
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 16
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 16
- 239000010410 layer Substances 0.000 description 16
- 238000007619 statistical method Methods 0.000 description 16
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 15
- 239000004575 stone Substances 0.000 description 15
- 206010014025 Ear swelling Diseases 0.000 description 14
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 14
- 210000002683 foot Anatomy 0.000 description 14
- 229960005287 lincomycin Drugs 0.000 description 14
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 14
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 13
- 230000001154 acute effect Effects 0.000 description 13
- 239000001768 carboxy methyl cellulose Substances 0.000 description 13
- 239000000679 carrageenan Substances 0.000 description 13
- 235000010418 carrageenan Nutrition 0.000 description 13
- 229920001525 carrageenan Polymers 0.000 description 13
- 229940113118 carrageenan Drugs 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 13
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 13
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 13
- 206010030113 Oedema Diseases 0.000 description 12
- 208000000114 Pain Threshold Diseases 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 230000004054 inflammatory process Effects 0.000 description 12
- 230000037040 pain threshold Effects 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 11
- 238000008789 Direct Bilirubin Methods 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 11
- 230000002159 abnormal effect Effects 0.000 description 11
- 238000009825 accumulation Methods 0.000 description 11
- 229960000583 acetic acid Drugs 0.000 description 11
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 11
- 230000002496 gastric effect Effects 0.000 description 11
- 239000013641 positive control Substances 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical group CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 10
- 230000009471 action Effects 0.000 description 10
- 230000002757 inflammatory effect Effects 0.000 description 10
- SMEROWZSTRWXGI-HVATVPOCSA-N lithocholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 SMEROWZSTRWXGI-HVATVPOCSA-N 0.000 description 10
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 10
- 231100000027 toxicology Toxicity 0.000 description 10
- 239000011575 calcium Substances 0.000 description 9
- 201000001883 cholelithiasis Diseases 0.000 description 9
- 238000011161 development Methods 0.000 description 9
- 230000018109 developmental process Effects 0.000 description 9
- 229960003957 dexamethasone Drugs 0.000 description 9
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical group C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 230000017074 necrotic cell death Effects 0.000 description 9
- 238000004321 preservation Methods 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 235000002598 Inula helenium Nutrition 0.000 description 8
- 244000116484 Inula helenium Species 0.000 description 8
- 210000000013 bile duct Anatomy 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 235000019658 bitter taste Nutrition 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 239000003651 drinking water Substances 0.000 description 8
- 235000020188 drinking water Nutrition 0.000 description 8
- 238000013401 experimental design Methods 0.000 description 8
- 210000000548 hind-foot Anatomy 0.000 description 8
- 238000005286 illumination Methods 0.000 description 8
- 239000002547 new drug Substances 0.000 description 8
- 230000001575 pathological effect Effects 0.000 description 8
- 230000007170 pathology Effects 0.000 description 8
- 239000008188 pellet Substances 0.000 description 8
- 238000007789 sealing Methods 0.000 description 8
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 7
- SMEROWZSTRWXGI-UHFFFAOYSA-N Lithocholsaeure Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 SMEROWZSTRWXGI-UHFFFAOYSA-N 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 7
- 229960001138 acetylsalicylic acid Drugs 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 229910001424 calcium ion Inorganic materials 0.000 description 7
- 230000037406 food intake Effects 0.000 description 7
- 210000004969 inflammatory cell Anatomy 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 210000004877 mucosa Anatomy 0.000 description 7
- 231100000915 pathological change Toxicity 0.000 description 7
- 230000036285 pathological change Effects 0.000 description 7
- 241000202726 Bupleurum Species 0.000 description 6
- 241001506371 Kadsura Species 0.000 description 6
- 241000207929 Scutellaria Species 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 235000010980 cellulose Nutrition 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 230000001684 chronic effect Effects 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000008298 dragée Substances 0.000 description 6
- 210000001198 duodenum Anatomy 0.000 description 6
- 210000000981 epithelium Anatomy 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 238000007726 management method Methods 0.000 description 6
- 238000000465 moulding Methods 0.000 description 6
- 230000003387 muscular Effects 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 239000007940 sugar coated tablet Substances 0.000 description 6
- 210000004876 tela submucosa Anatomy 0.000 description 6
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 5
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 5
- 208000035143 Bacterial infection Diseases 0.000 description 5
- 206010008635 Cholestasis Diseases 0.000 description 5
- 239000004380 Cholic acid Substances 0.000 description 5
- 238000010156 Dunnett's T3 test Methods 0.000 description 5
- 244000236658 Paeonia lactiflora Species 0.000 description 5
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 5
- 241001106477 Paeoniaceae Species 0.000 description 5
- FPVRUILUEYSIMD-RPRRAYFGSA-N [(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(C)=O)[C@@]1(C)C[C@@H]2O FPVRUILUEYSIMD-RPRRAYFGSA-N 0.000 description 5
- 201000010312 acute cholangitis Diseases 0.000 description 5
- 230000002411 adverse Effects 0.000 description 5
- 208000022362 bacterial infectious disease Diseases 0.000 description 5
- 239000003613 bile acid Substances 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 231100000359 cholestasis Toxicity 0.000 description 5
- 230000007870 cholestasis Effects 0.000 description 5
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 5
- 235000019416 cholic acid Nutrition 0.000 description 5
- 229960002471 cholic acid Drugs 0.000 description 5
- 230000007850 degeneration Effects 0.000 description 5
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 5
- 230000008595 infiltration Effects 0.000 description 5
- 238000001764 infiltration Methods 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 238000010926 purge Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 229940126673 western medicines Drugs 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 4
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 208000001130 gallstones Diseases 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 210000005229 liver cell Anatomy 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 210000000440 neutrophil Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 239000007929 subcutaneous injection Substances 0.000 description 4
- 238000010254 subcutaneous injection Methods 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 3
- 108010082126 Alanine transaminase Proteins 0.000 description 3
- 241000092668 Artemisia capillaris Species 0.000 description 3
- 235000008658 Artemisia capillaris Nutrition 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 241000124879 Grus leucogeranus Species 0.000 description 3
- 240000001307 Myosotis scorpioides Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000003445 biliary tract Anatomy 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000008845 cholagoga Substances 0.000 description 3
- 229940124571 cholagogue Drugs 0.000 description 3
- 208000037976 chronic inflammation Diseases 0.000 description 3
- 230000006020 chronic inflammation Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 229960003657 dexamethasone acetate Drugs 0.000 description 3
- 239000002662 enteric coated tablet Substances 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 230000036449 good health Effects 0.000 description 3
- POUMFISTNHIPTI-BOMBIWCESA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 POUMFISTNHIPTI-BOMBIWCESA-N 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 229960001595 lincomycin hydrochloride Drugs 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000004576 sand Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 241000173529 Aconitum napellus Species 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 240000001008 Dimocarpus longan Species 0.000 description 2
- 235000000235 Euphoria longan Nutrition 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010023129 Jaundice cholestatic Diseases 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 201000005267 Obstructive Jaundice Diseases 0.000 description 2
- 240000004534 Scutellaria baicalensis Species 0.000 description 2
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 229940023019 aconite Drugs 0.000 description 2
- 208000038016 acute inflammation Diseases 0.000 description 2
- 230000006022 acute inflammation Effects 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 210000000702 aorta abdominal Anatomy 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000002192 cholecystectomy Methods 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 230000002183 duodenal effect Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 238000000556 factor analysis Methods 0.000 description 2
- 201000003350 gallbladder adenoma Diseases 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 239000002874 hemostatic agent Substances 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 229940126532 prescription medicine Drugs 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 102000014898 transaminase activity proteins Human genes 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 1
- 239000001074 1-methoxy-4-[(E)-prop-1-enyl]benzene Substances 0.000 description 1
- 208000007743 Acute Abdomen Diseases 0.000 description 1
- 208000003200 Adenoma Diseases 0.000 description 1
- 206010001233 Adenoma benign Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 101710142885 Arginine N-succinyltransferase Proteins 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 206010061695 Biliary tract infection Diseases 0.000 description 1
- 206010004716 Binge eating Diseases 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 238000003650 Calcium Assay Kit Methods 0.000 description 1
- 208000009458 Carcinoma in Situ Diseases 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 208000004845 Cholecystolithiasis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 102000002397 Kinins Human genes 0.000 description 1
- 108010093008 Kinins Proteins 0.000 description 1
- 208000015924 Lithiasis Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 102100023105 Sialin Human genes 0.000 description 1
- 101710105284 Sialin Proteins 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010066901 Treatment failure Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 208000014679 binge eating disease Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 230000002189 cholecystokinetic effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 210000001953 common bile duct Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000001096 cystic duct Anatomy 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 230000004970 emotional disturbance Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229940124307 fluoroquinolone Drugs 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 230000005989 gallbladder dysfunction Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000001703 glandular epithelial cell Anatomy 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 238000011597 hartley guinea pig Methods 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 206010020488 hydrocele Diseases 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 239000009384 kangtai Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000000387 litholytic effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000015263 low fat diet Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 210000004514 sphincter of oddi Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 1
- 229960001661 ursodiol Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000008468 xiao-ban-xia-tang Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (11)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110621563.2A CN115429866B (zh) | 2021-06-04 | 2021-06-04 | 一种治疗胆囊炎的中药组合物及其制备方法 |
PCT/CN2022/096578 WO2022253268A1 (zh) | 2021-06-04 | 2022-06-01 | 一种治疗胆囊炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110621563.2A CN115429866B (zh) | 2021-06-04 | 2021-06-04 | 一种治疗胆囊炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115429866A CN115429866A (zh) | 2022-12-06 |
CN115429866B true CN115429866B (zh) | 2024-01-05 |
Family
ID=84272079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110621563.2A Active CN115429866B (zh) | 2021-06-04 | 2021-06-04 | 一种治疗胆囊炎的中药组合物及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115429866B (zh) |
WO (1) | WO2022253268A1 (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101417029A (zh) * | 2008-11-19 | 2009-04-29 | 吉林省中医药科学院 | 一种治疗胆囊炎的药物组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102370949A (zh) * | 2011-11-17 | 2012-03-14 | 中国中医科学院中医临床基础医学研究所 | 一种治疗胆囊炎的中药复方制剂及其制备方法 |
CN103446555A (zh) * | 2012-05-30 | 2013-12-18 | 付勇 | 一种治疗胆囊炎的组合物中药 |
CN103169924B (zh) * | 2013-04-12 | 2014-07-02 | 王燕 | 治疗急性胆囊炎的中药丸剂 |
CN104740271A (zh) * | 2013-12-25 | 2015-07-01 | 储海燕 | 一种治疗急性胆囊炎的中药制剂 |
CN108452244A (zh) * | 2017-02-22 | 2018-08-28 | 郝纪涛 | 一种治疗胆囊炎的中药方 |
-
2021
- 2021-06-04 CN CN202110621563.2A patent/CN115429866B/zh active Active
-
2022
- 2022-06-01 WO PCT/CN2022/096578 patent/WO2022253268A1/zh active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101417029A (zh) * | 2008-11-19 | 2009-04-29 | 吉林省中医药科学院 | 一种治疗胆囊炎的药物组合物 |
Non-Patent Citations (3)
Title |
---|
大柴胡汤加减治疗慢性胆囊炎伴胆石症126例;武喜龙;安徽中医学院学报;-;第13卷(第01期);第28页 * |
老年胆囊炎、胆石症中西医结合治疗探讨;张坚良;中国中西医结合杂志;-;第17卷(第07期);第429-430页 * |
自拟疏肝利胆汤治疗慢性胆囊炎78例报告;马兰英;甘肃中医;第17卷(第07期);第14页 * |
Also Published As
Publication number | Publication date |
---|---|
WO2022253268A1 (zh) | 2022-12-08 |
CN115429866A (zh) | 2022-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103830577B (zh) | 一种治疗肝胆结石和肾结石的药物组合物及其用途 | |
CN103263615A (zh) | 用于治疗胃病、肠炎、胆囊炎的中药制剂及其制备方法 | |
CN103251874A (zh) | 一种治疗肝、胆结石及并发症的中药及其制造方法 | |
CN104147536A (zh) | 一种治疗痔疮的药物组合物及其制备方法 | |
CN115429866B (zh) | 一种治疗胆囊炎的中药组合物及其制备方法 | |
CN104324317B (zh) | 一种治疗子宫肌瘤的中药组合物及医药用途 | |
CN105250748A (zh) | 一种治疗宫颈癌的中药及制备方法 | |
CN100431578C (zh) | 一种治疗前列腺增生的中药制剂 | |
CN103386101B (zh) | 一种治疗非特异性膀胱炎的中药制剂及其制备方法 | |
CN105056201A (zh) | 一种治疗浆细胞性乳腺炎的中药制剂及其制备方法 | |
CN104971271A (zh) | 一种治疗瘀湿化热型前列腺增生的药物及制备方法 | |
CN104940813A (zh) | 一种治疗胆石症、胆囊炎的中药组合物及制备方法 | |
CN104337901A (zh) | 一种治疗非特异性膀胱炎的中药制剂及其制备方法 | |
CN103989924A (zh) | 一种治疗老年性便秘的中药组合物灌肠剂 | |
CN102293887A (zh) | 治疗胆胃肠病症的清泄舒胶囊 | |
CN103432335B (zh) | 一种治疗乳糜尿的药物及其制备方法 | |
CN105770538A (zh) | 一种治疗血液透析患者血管通路局部硬结的中药 | |
CN104208291A (zh) | 一种治疗热淋的中药制剂及其制备方法 | |
CN100594927C (zh) | 一种治疗慢性肠炎、慢性菌痢及肠癌的药物 | |
CN104436063A (zh) | 一种治疗湿热淤毒型子宫颈癌的中药及制备方法 | |
CN105168847A (zh) | 一种用于治疗幽门螺杆菌感染性消化性溃疡的中药 | |
CN105125940A (zh) | 一种用于治疗肺脓肿的中药 | |
CN104383467A (zh) | 一种治疗肝郁气滞型子宫颈癌的中药及制备方法 | |
CN114470144A (zh) | 用于抑制前列腺纤维化的前列消汤及其制备方法 | |
CN102688469A (zh) | 一种中药提取物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230310 Address after: 102600 17 Tianfu street, Daxing biomedical industry base, Zhongguancun Science and Technology Park, Daxing District, Beijing Applicant after: BEIJING YILING PHARMACEUTICAL Co.,Ltd. Address before: 050035 No. 238 Tianshan Avenue, Shijiazhuang hi tech Development Zone, Hebei, China Applicant before: HEBEI YILING MEDICINE RESEARCH INSTITUTE Co.,Ltd. |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230824 Address after: 050035 No. 238 Tianshan Avenue, Shijiazhuang hi tech Development Zone, Hebei, China Applicant after: Shijiazhuang Yiling Pharmaceutical Co.,Ltd. Address before: 102600 17 Tianfu street, Daxing biomedical industry base, Zhongguancun Science and Technology Park, Daxing District, Beijing Applicant before: BEIJING YILING PHARMACEUTICAL Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240509 Address after: 102600 17 Tianfu street, Daxing biomedical industry base, Zhongguancun Science and Technology Park, Daxing District, Beijing Patentee after: BEIJING YILING PHARMACEUTICAL Co.,Ltd. Country or region after: China Address before: 050035 No. 238 Tianshan Avenue, Shijiazhuang hi tech Development Zone, Hebei, China Patentee before: Shijiazhuang Yiling Pharmaceutical Co.,Ltd. Country or region before: China |